Literature DB >> 16896957

C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Leslie K Jacobsen1, Kenneth R Pugh, W Einar Mencl, Joel Gelernter.   

Abstract

RATIONALE: In both animals and humans, nicotine produces behavioral effects that vary across individuals. Studies examining the role of genetic variability in modulating individual response to nicotine in humans have increased, with recent work showing that genetic variation at the dopamine D2 receptor (DRD2) predicts response to pharmacotherapy for tobacco dependence.
OBJECTIVES: To determine whether a polymorphism of the DRD2 gene, C957T, that alters DRD2 binding availability in humans modifies the effects of nicotine on verbal working memory performance and on processing efficiency of brain regions that support verbal working memory.
MATERIALS AND METHODS: Working memory and brain function were assessed in 36 adult subjects (15,957T allele carriers and 21,957C homozygotes), each of whom was studied twice, once after placement of a placebo patch and once after placement of a nicotine patch. Brain function was assessed using functional magnetic resonance imaging while the subjects performed a verbal working memory task.
RESULTS: During performance of a task with high verbal working memory load, nicotine administration worsened performance accuracy and reduced the processing efficiency of brain regions that support phonological rehearsal during verbal working memory in carriers of the 957T allele.
CONCLUSIONS: These findings are consistent with the notion that genetic variation in DRD2 contributes to individual variation in a range of behavioral and brain responses to nicotine in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896957     DOI: 10.1007/s00213-006-0469-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  86 in total

1.  Smoking history and nicotine effects on cognitive performance.

Authors:  M Ernst; S J Heishman; L Spurgeon; E D London
Journal:  Neuropsychopharmacology       Date:  2001-09       Impact factor: 7.853

2.  Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.

Authors:  D V Poltavski; T Petros
Journal:  Physiol Behav       Date:  2004-11-23

3.  Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

Authors:  Sargo Aalto; Anna Brück; Matti Laine; Kjell Någren; Juha O Rinne
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

4.  Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation.

Authors:  Sasha E B Gibbs; Mark D'Esposito
Journal:  Cogn Affect Behav Neurosci       Date:  2005-06       Impact factor: 3.282

5.  Faster P300 latency after smoking in visual but not auditory oddball tasks.

Authors:  M E Houlihan; W S Pritchard; J H Robinson
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

6.  Presynaptic nicotinic receptors facilitate monoaminergic transmission.

Authors:  X Li; D G Rainnie; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

7.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

8.  Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.

Authors:  G E Swan; A M Valdes; H Z Ring; T V Khroyan; L M Jack; C C Ton; S J Curry; T McAfee
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

9.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

10.  C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.

Authors:  M Hirvonen; A Laakso; K Någren; J O Rinne; T Pohjalainen; J Hietala
Journal:  Mol Psychiatry       Date:  2004-12       Impact factor: 15.992

View more
  32 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory.

Authors:  Shirley Y Hill; Sarah Lichenstein; Shuhui Wang; Howard Carter; Michael McDermott
Journal:  Adv J Mol Imaging       Date:  2013-10-01

3.  Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.

Authors:  Huiping Zhang; Henry R Kranzler; James Poling; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

4.  Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory.

Authors:  Matthew T Sutherland; Thomas J Ross; Diaá M Shakleya; Marilyn A Huestis; Elliot A Stein
Journal:  Psychopharmacology (Berl)       Date:  2010-09-23       Impact factor: 4.530

5.  Allelic variation of calsyntenin 2 (CLSTN2) modulates the impact of developmental tobacco smoke exposure on mnemonic processing in adolescents.

Authors:  Leslie K Jacobsen; Marina R Picciotto; Christopher J Heath; W Einar Mencl; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

6.  Dopaminergic Genetic Polymorphisms Predict Rule-based Category Learning.

Authors:  Kaileigh A Byrne; Tyler Davis; Darrell A Worthy
Journal:  J Cogn Neurosci       Date:  2016-02-26       Impact factor: 3.225

7.  Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.

Authors:  Stefan Ahrens; Sebastian Markett; Thomas P K Breckel; Oliver Behler; Martin Reuter; Christiane M Thiel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-03       Impact factor: 4.530

Review 8.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

Review 9.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

Review 10.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.